MECHANISMS OF COMPLEMENT INDUCED ENDOTHELIAL DYSFUNCTION
补体引起的内皮功能障碍的机制
基本信息
- 批准号:2910613
- 负责人:
- 金额:$ 30.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) There is
considerable recent interest in the activation of complement proteins
during the early stages of myocardial ischemia and reperfusion. In the
present proposal this research team continue their focus on endothelial
injury, with particular emphasis on the alternative complement pathway.
They provide excellent evidence that hypoxia alone does not activate
this cascade; rather, reperfusion and oxygen radicals produce C5b, the
linchpin for sequential assembly of the C5b-9 membrane attack complex.
This transmembrane pore complex could directly injure vascular
endothelium by a number of mechanisms, including production of oxygen
metabolites. The role of the C5a fragments is projected to involve
synergistic activation of neutrophils compounding vascular injury. The
five year proposal consists of experiments investigating complement
mechanisms in isolated vessels (both large and micro-vessels, years 1
and 2), verification of complement deposition after hypoxia-reoxygenation
on small and large coronary artery vessels and endothelial cells (year
3), and lastly delineation of the alternative complement pathways during
myocardial ischemia-reperfusion in a pig model, with special emphasis
on therapeutic attenuation of C5b-9 mediated injury in vivo.
描述:(改编自申请人摘要)
最近对补体蛋白的激活产生了相当大的兴趣
在心肌缺血和再灌注的早期阶段。 在
目前,该研究小组继续专注于内皮细胞
损伤,特别强调替代补体途径。
他们提供了很好的证据,证明缺氧本身并不能激活
相反,再灌注和氧自由基产生C5b,
C5b-9膜攻击复合物顺序组装的关键。
这种跨膜孔复合物可直接损伤血管
内皮细胞通过多种机制,包括产生氧气
代谢物。 C5a片段的作用预计涉及
中性粒细胞的协同活化复合血管损伤。 的
五年计划包括实验研究补充
孤立血管中的机制(包括大血管和微血管,1年
缺氧-复氧后补体沉积的验证
对小和大冠状动脉血管和内皮细胞的影响(年
3),最后描绘了替代补体途径,
猪心肌缺血再灌注模型,特别强调
对C5b-9介导的体内损伤的治疗性衰减的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY L STAHL其他文献
GREGORY L STAHL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY L STAHL', 18)}}的其他基金
Innate Immunity, Biomarkers and Myocardial Infarction
先天免疫、生物标志物和心肌梗塞
- 批准号:
7935403 - 财政年份:2009
- 资助金额:
$ 30.13万 - 项目类别:
Innate Immunity, Biomarkers and Myocardial Infarction
先天免疫、生物标志物和心肌梗塞
- 批准号:
7805972 - 财政年份:2009
- 资助金额:
$ 30.13万 - 项目类别:
Mechanisms of complement induced endothelial dysfunction
补体诱导内皮功能障碍的机制
- 批准号:
7676512 - 财政年份:1996
- 资助金额:
$ 30.13万 - 项目类别:
相似海外基金
Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases
特发性肺纤维化和其他进行性纤维化间质性肺疾病中的补体途径激活
- 批准号:
10590870 - 财政年份:2023
- 资助金额:
$ 30.13万 - 项目类别:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中
- 批准号:
10650372 - 财政年份:2022
- 资助金额:
$ 30.13万 - 项目类别:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
APOE4 依赖性调节脑脊液补体通路激活在阿尔茨海默病的发展过程中
- 批准号:
10871775 - 财政年份:2022
- 资助金额:
$ 30.13万 - 项目类别:
Elucidation of the mechanism of peritoneal dialysis-related peritoneal injury through complement pathway and establishment of novel anti-complement therapy.
通过补体途径阐明腹膜透析相关腹膜损伤的机制并建立新型抗补体疗法。
- 批准号:
21K08275 - 财政年份:2021
- 资助金额:
$ 30.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
- 批准号:
10221291 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
- 批准号:
9886859 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
- 批准号:
10080727 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:
Alternative complement pathway regulation of beta cell homeostasis
β细胞稳态的替代补体途径调节
- 批准号:
10530710 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:
Role of classical complement pathway underling glial phenotypes and multiple pathologies in Alzheimer's disease and cerebrovascular disease
经典补体途径在神经胶质表型和多种病理学中在阿尔茨海默病和脑血管疾病中的作用
- 批准号:
10256776 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:
Role of classical complement pathway underling glial phenotypes and multiple pathologies in Alzheimer's disease and cerebrovascular disease
经典补体途径在神经胶质表型和多种病理学中在阿尔茨海默病和脑血管疾病中的作用
- 批准号:
10468286 - 财政年份:2020
- 资助金额:
$ 30.13万 - 项目类别:














{{item.name}}会员




